Product
JNJ-74856665
1 clinical trial
3 indications
Indication
Acute Myeloid LeukemiaIndication
Myelodysplastic SyndromesIndication
Chronic Myelomonocytic LeukemiaClinical trial
A Phase 1, FIH, Dose Escalation Study of JNJ-74856665 (Dihydroorotate Dehydrogenase [DHODH] Inhibitor) Alone or in Combination in Participants With AML or MDSStatus: Active (not recruiting), Estimated PCD: 2024-07-31